Saturday 17 October 2026 Export PDSB’s income statement to Excel — free account

PDS Biotechnology Corporation

In the quarter to June 2026, EPS grew 14.3%, free cash flow grew 69.3% and total debt fell 66.6%, each against the same quarter a year earlier.

1.12 0.18 −13.85%

Follow PDSB

Alert me

Market cap: $72.8M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(221.81%)	(244.16%)	(254.09%)	(543.97%)
ROA Full definition →		(80.05%)	(90.95%)	(93.05%)	(136.65%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(237.49%)	(182.60%)	(259.50%)	653.10%
Free Cash Flow per Share Full definition →		(0.69)	(0.60)	(0.42)	(0.30)
Free Cash Flow Full definition →		(32.28)	(27.75)	(23.09)	(16.78)
Other line items
Cash ROIC Full definition →		(67.86%)	(52.51%)	(63.83%)	(264.35%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		(6.06)	(5.91)	(5.34)	(4.18)
Operating CF/Net income Full definition →		0.93	0.80	0.69	0.50
Depreciation/Fixed assets Full definition →		11.45	13.43	15.61	5.33
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.69)	(0.60)	(0.42)	(0.30)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly